CAS 2057463-74-6

(2′R,3aS,4E,6′R,11R,12R,13S,14R,15R,16S,17R,18E,22S,26S,27aS,28R)-13-[[(2S,5S,6S)-5-(Dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3′,3a,4′,5′,6,6′,7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,17,27a-hexahydroxy-6′-[(2R)-2-hydroxybutyl]-2,2,11,15,17,28-hexamethylspiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2′-[2H]pyran]-20-one

Description:

The chemical substance identified by the name provided is a complex organic molecule characterized by a multi-ring structure and numerous stereocenters, indicating significant stereochemical complexity. It features a spirocyclic framework, which is a hallmark of many natural products and pharmaceuticals, suggesting potential biological activity. The presence of multiple hydroxyl groups indicates that the compound may exhibit strong hydrogen bonding capabilities, influencing its solubility and reactivity. Additionally, the dimethylamino group suggests potential interactions with biological systems, possibly affecting its pharmacological properties. The molecule's intricate structure, including various functional groups such as ethers and ketones, may contribute to its overall stability and reactivity. Given its complexity, this compound may be of interest in medicinal chemistry, particularly in the development of new therapeutic agents. The CAS number 2057463-74-6 serves as a unique identifier for this substance, facilitating its recognition in scientific literature and databases. Overall, the characteristics of this compound suggest a rich potential for research and application in various fields, including drug discovery and organic synthesis.

Formula: C₄₉H₈₅NO₁₄

InChI: InChI=1S/C49H85NO14/c1-11-34(51)26-35-19-17-24-48(62-35)28-37-30(2)38(63-48)29-49(58)33(27-45(5,6)64-49)18-15-13-12-14-16-23-46(7,56)44(55)42(61-40-21-20-36(50(9)10)32(4)59-40)41(53)31(3)43(54)47(8,57)25-22-39(52)60-37/h15,18,22,25,30-38,40-44,51,53-58H,11-14,16-17,19-21,23-24,26-29H2,1-10H3/b18-15+,25-22+/t30-,31+,32-,33+,34+,35+,36-,37-,38-,40-,41+,42-,43-,44+,46+,47+,48+,49-/m0/s1

InChI key: InChIKey=XGECDDPXIKFBTE-AUFVQPSPSA-N

SMILES: C([C@@H](CC)O)[C@@H]1O[C@@]2(O[C@]3(C[C@@]4(O)[C@@](CC(C)(C)O4)(/C=C/CCCCC[C@@](C)(O)[C@H](O)[C@@H](O[C@@H]5O[C@@H](C)[C@@H](N(C)C)CC5)[C@H](O)[C@@H](C)[C@H](O)[C@](C)(O)\C=C\C(=O)O[C@@](C2)([C@@H]3C)[H])[H])[H])CCC1

Synonyms:

• Ossamycin
• Spiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2'-[2H]pyran]-20-one, 13-[[(2S,5S,6S)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3',3a,4',5',6,6',7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,17,27a-hexahydroxy-6'-[(2R)-2-hydroxybutyl]-2...
• NSC 76627
• Spiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2′-[2H]pyran]-20-one, 13-[[(2S,5S,6S)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3′,3a,4′,5′,6,6′,7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,17,27a-hexahydroxy-6′-[(2R)-2-hydroxybutyl]-2,2,11,15,17,28-hexamethyl-, (2′R,3aS,4E,6′R,11R,12R,13S,14R,15R,16S,17R,18E,22S,26S,27aS,28R)-
• (2′R,3aS,4E,6′R,11R,12R,13S,14R,15R,16S,17R,18E,22S,26S,27aS,28R)-13-[[(2S,5S,6S)-5-(Dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3′,3a,4′,5′,6,6′,7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,17,27a-hexahydroxy-6′-[(2R)-2-hydroxybutyl]-2,2,11,15,17,28-hexamethylspiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2′-[2H]pyran]-20-one

Ossamycin

CAS: 2057463-74-6

Ossamycin is a macrolide antibiotic with notable antifungal properties and a relatively weak effect against Gram-positive bacteria. In cell culture studies, it inhibits L cells, Epstein-Barr ascites carcinoma cells, KB cells, Sarcoma-180 cells, L-1210 cells, and HeLa cells, with IC50 values of 0.007, 0.008, 0.005, 0.008, 0.003, and 0.005 μg/mL, respectively.

Formula: C₄₉H₈₅NO₁₄

Color and Shape: Solid

Molecular weight: 912.198

Ref: TM-TN10098